Articles with public access mandates - Walter K. KraftLearn more
Not available anywhere: 1
Pharmacokinetics of Intraperitoneal Vancomycin in Patients on Automated Peritoneal Dialysis: PO0997
E Lam, WK Kraft, DF Stickle, BM Piraino, JJ Zhang
Journal of the American Society of Nephrology 32 (10S), 336, 2021
Mandates: US National Institutes of Health
Recused: 2
Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: a cohort study
N Chalouhi, B Daou, T Okabe, RM Starke, R Dalyai, CD Bovenzi, ...
Journal of neurosurgery 125 (3), 730-736, 2016
Mandates: American Heart Association
Responsible authors: F Rincon
Clinical pharmacology: a paradigm for individualized medicine
SA Waldman, WK Kraft, TJ Nelson, A Terzic
Biomarkers in Medicine 3 (6), 679-684, 2009
Mandates: US National Institutes of Health
Responsible authors: A Terzic
Available somewhere: 46
Acid peptic diseases: pharmacological approach to treatment
A Mejia, WK Kraft
Expert review of clinical pharmacology 2 (3), 295-314, 2009
Mandates: US National Institutes of Health
Buprenorphine for the treatment of the neonatal abstinence syndrome
WK Kraft, SC Adeniyi-Jones, I Chervoneva, JS Greenspan, D Abatemarco, ...
New England Journal of Medicine 376 (24), 2341-2348, 2017
Mandates: US National Institutes of Health
Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial
WK Kraft, E Gibson, K Dysart, VS Damle, JL LaRusso, JS Greenspan, ...
Pediatrics 122 (3), e601-e607, 2008
Mandates: US National Institutes of Health
Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome
WK Kraft, K Dysart, JS Greenspan, E Gibson, K Kaltenbach, ME Ehrlich
Addiction 106 (3), 574-580, 2011
Mandates: US National Institutes of Health
Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS)
AK Mangat, GM Schmölzer, WK Kraft
Seminars in Fetal and Neonatal Medicine 24 (2), 133-141, 2019
Mandates: US National Institutes of Health, Heart and Stroke Foundation of Canada
Neonatal abstinence syndrome: pharmacologic strategies for the mother and infant
WK Kraft, MW Stover, JM Davis
Seminars in Perinatology 40 (3), 203-212, 2016
Mandates: US National Institutes of Health
Ethanol pharmacokinetics in neonates and infants
E Marek, WK Kraft
Current Therapeutic Research 76, 90-97, 2014
Mandates: US National Institutes of Health
Pharmacologic and clinical evaluation of posaconazole
JN Moore, JR Healy, WK Kraft
Expert review of clinical pharmacology 8 (3), 321-334, 2015
Mandates: US National Institutes of Health
Pharmacologic management of the opioid neonatal abstinence syndrome
WK Kraft, JN van den Anker
Pediatric Clinics of North America 59 (5), 1147, 2012
Mandates: US National Institutes of Health
Tumor necrosis factor inhibitors in psoriatic arthritis
S Mantravadi, A Ogdie, WK Kraft
Expert review of clinical pharmacology 10 (8), 899-910, 2017
Mandates: US National Institutes of Health
Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling
J Elia, G Ungal, C Kao, A Ambrosini, N De Jesus-Rosario, L Larsen, ...
Nature communications 9 (1), 4, 2018
Mandates: US National Institutes of Health
Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients
AE Snook, TR Baybutt, B Xiang, TS Abraham, JC Flickinger, T Hyslop, ...
Journal for Immunotherapy of Cancer 7, 1-12, 2019
Mandates: US National Institutes of Health
Buprenorphine in neonatal abstinence syndrome
WK Kraft
Clinical Pharmacology & Therapeutics 103 (1), 112-119, 2018
Mandates: US National Institutes of Health
Pharmacokinetics and Pharmacodynamics of MK‐5046, a Bombesin Receptor Subtype‐3 (BRS‐3) Agonist, in Healthy Patients
ML Reitman, V Dishy, A Moreau, WS Denney, C Liu, WK Kraft, AV Mejia, ...
The Journal of Clinical Pharmacology 52 (9), 1306-1316, 2012
Mandates: US National Institutes of Health
A population pharmacokinetic model for vancomycin in adult patients receiving extracorporeal membrane oxygenation therapy
JN Moore, JR Healy, BN Thoma, MM Peahota, M Ahamadi, L Schmidt, ...
CPT: pharmacometrics & systems pharmacology 5 (9), 495-502, 2016
Mandates: US National Institutes of Health
Population pharmacokinetic model of sublingual buprenorphine in neonatal abstinence syndrome
CM Ng, E Dombrowsky, H Lin, ME Erlich, DE Moody, JS Barrett, WK Kraft
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (7 …, 2015
Mandates: US National Institutes of Health
Bioactivity of oral linaclotide in human colorectum for cancer chemoprevention
DS Weinberg, JE Lin, NR Foster, G Della'Zanna, A Umar, D Seisler, ...
Cancer Prevention Research 10 (6), 345-354, 2017
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program